Heinz and Kraft, a favorable food pairing?
With consumer’s tastes difficult to predict and organic trends on the rise, how successful can Kraft be globally?
Are Industry Analysts bullish on S&P 500 Companies with less global exposure?
Plus: Why are analysts predicting a double-digit price increase for the Energy sector?
Is Macerich's poison pill too bitter to swallow?
Macerich’s staggering of its board in response to a hostile bid is unprecedented in 12 years of FactSet hostile deal coverage.
U.S. M&A deal activity down 5.7%, private equity activity up 10.1% in February
U.S. M&A news and trends from FactSet Mergers for March 2015.
Does ISS pull the strings in a proxy fight?
Activists and corporate targets seek out the endorsement of ISS, as it may be a deciding factor in close proxy contests.
Steady Improvement Projected for U.S. Homebuilders
Homebuilding analysts are projecting sliding sales trends to reverse in 2015.
Without NOL protections, short-term activism value gains often become long-term losses
Most companies that experienced sufficient net operating losses to deem it necessary to protect the asset’s value could not...
Proxy access wolf packs in sheep's clothing
Proxy access may be much more than another checkbox on the shareholder rights scorecard.
Poison pills and net operating loss assets: protecting the balance sheet or the board of directors?
The overall activism rate against companies with NOL-specific poison pills is similar to the rate for companies that adopt...
2014 Poison Pill Impetus: Why are U.S. companies adopting poison pills?
In 2014, 57 poison pills were adopted by 54 distinct U.S. incorporated companies.
Evaluate portfolio risk with Axioma's macroeconomic model on FactSet
Axioma's macroeconomic model is now available on FactSet.
Public pension funds striving for proxy access may unsettle company boards
New York City Comptroller Scott Stringer's “Boardroom Accountability Project 2015” takes aim at 75 public companies with issues...
The best way to understand what makes FactSet different is to see it for yourself. We've worked with investment professionals for 40 years, so we understand your workflow and know precisely how to help. Talk to us about your challenges, and we’ll help you design the most effective solutions for your firm with everything you need — and not what you don’t.
The information contained in this article is not investment advice. FactSet does not endorse or recommend any investments and assumes no liability for any consequence relating directly or indirectly to any action or inaction taken based on the information contained in this article.